KoBioLabs Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 4, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	73,403	111,270	103,844	160,602	191,231	335,174
Market Cap Growth	-22.46%	7.15%	-35.34%	-16.02%	-42.95%	-50.18%
Enterprise Value	59,713	93,073	80,193	121,886	127,584	294,643
Last Close Price	3780.00	5730.00	5360.00	8510.00	11050.00	20600.00
PS Ratio	1.03	1.61	1.52	4.85	16.48	115.84
PB Ratio	1.56	2.26	1.87	2.60	2.00	3.70
P/TBV Ratio	2.49	3.53	2.79	3.65	2.51	3.75
EV/Sales Ratio	0.84	1.34	1.17	3.68	10.99	101.84
Debt / Equity Ratio	0.35	0.28	0.30	0.30	0.14	0.10
Net Debt / Equity Ratio	-0.65	-0.68	-0.71	-0.78	-0.83	-0.88
Net Debt / EBITDA Ratio	5.02	4.85	9.08	2.83	4.08	4.94
Net Debt / FCF Ratio	10.26	5.48	6.55	1.66	2.53	4.42
Asset Turnover	0.76	0.72	0.63	0.28	0.10	0.04
Inventory Turnover	2.88	3.59	7.27	7.72	5.88	5.50
Quick Ratio	3.30	3.87	4.28	3.36	10.95	13.45
Current Ratio	3.91	4.50	4.82	3.58	11.46	14.42
Return on Equity (ROE)	-8.27%	-13.31%	-7.87%	-19.28%	-25.14%	-21.07%
Return on Assets (ROA)	-5.88%	-6.24%	-3.98%	-9.67%	-11.07%	-12.47%
Return on Capital Employed (ROCE)	-11.70%	-12.40%	-7.80%	-19.70%	-17.60%	-16.60%
Earnings Yield	-5.08%	-5.69%	-5.10%	-8.63%	-11.46%	-4.59%
FCF Yield	-4.04%	-5.46%	-5.77%	-18.04%	-16.34%	-5.37%
Buyback Yield / Dilution	-	-1.11%	-3.61%	-10.30%	-4.68%	-49.69%